China Kangtai Cactus Biotech Inc. (OTCBB:CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, has signed a joint manufacturing agreement with China Tobacco Import and Export Shandong Corporation (China Tobacco Shandong), a subsidiary of China National Tobacco Corporation, to manufacture cactus cigarettes under the name of ?Tai Shan Sheng Chao.?

The Shandong Province Government authorized the agreement in November. The company will manufacture this new brand using a new paper process technology with China Tobacco Shandong's subsidiary, Qingdao Cigarette Factory. Plans are to begin full production in February 2011.

Qingdao Cigarette Factory, established by United Kingdom Tobacco Company in 1919, is a well-established tobacco company with high-end technology and advanced equipment. Its parent company, China Tobacco Shandong, founded in 1985, mainly exports and imports tobacco and tobacco manufacturing equipments. In its 25 years of operations it has exported over 216,000 tons of tobacco to 30 different countries and has accumulated over $461 million in revenue.

China Kangtai Cactus CEO Mr. Jinjiang Wang said, ?This agreement is a very important breakthrough for our cactus cigarette business. In China, cigarette manufacturing is a government monopoly, which designates only one cigarette brand for each province. We are now the first publicly held company to sign a joint manufacturing agreement with a government-owned cigarette manufacturer. This will enable us to make important progress in growing market share for our products and further enhances our revenue growth potential.?

China Tobacco Shandong General Manager Jianli Bi said, ?This agreement creates mutual benefit for both companies. The low-nicotine and non-nicotine cactus cigarette product coincides with the government's initial step to promote less harmful products to the huge smoking population in China. It is estimated that more than 300 million people in China are regular smokers. Furthermore, we plan to export ?Tai Shan Sheng Chao? cigarettes to Russia, South Korea and Japan through our established sales channels. We are confident that cactus-based cigarettes have a promising future to broaden shareholder value for both companies in a long term.?

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality ?green? products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

China Kangtai's online investor kit, including an investment profile, press releases, current price quotes, stock charts and more is available at http://www.hawkassociates.com/profile/ckgt.cfm. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Investor Contacts:
Hawk Associates
Frank Hawkins or Amy Lin, 305-451-1888
kangtai@hawkassociates.com